Fostering deliberations about health innovation: what do we want to know from publics?

As more complex and uncertain forms of health innovation keep emerging, scholars are increasingly voicing arguments in favour of public involvement in health innovation policy. The current conceptualization of this involvement is, however, somewhat problematic as it tends to assume that scientific facts form a "hard," indisputable core around which "soft," relative values can be attached. This paper, by giving precedence to epistemological issues, explores what there is to know from public involvement. We argue that knowledge and normative assumptions are co-constitutive of each other and pivotal to the ways in which both experts and non-experts reason about health innovations. Because knowledge and normative assumptions are different but interrelated ways of reasoning, public involvement initiatives need to emphasise deliberative processes that maximise mutual learning within and across various groups of both experts and non-experts (who, we argue, all belong to the "publics"). Hence, we believe that what researchers might wish to know from publics is how their reasoning is anchored in normative assumptions (what makes a given innovation desirable?) and in knowledge about the plausibility of their effects (are they likely to be realised?). Accordingly, one sensible goal of greater public involvement in health innovation policy would be to refine normative assumptions and make their articulation with scientific observations explicit and openly contestable. The paper concludes that we must differentiate between normative assumptions and knowledge, rather than set up a dichotomy between them or confound them.

[1]  Katie J. Ward,et al.  The 'expert patient': empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet. , 2005, Social science & medicine.

[2]  Luc Boltanski,et al.  The reality of moral expectations: A sociology of situated judgement , 2000 .

[3]  J. Denis,et al.  Marginal voices in the media coverage of controversial health interventions: how do they contribute to the public understanding of science? , 2010, Public understanding of science.

[4]  D. Timmermans,et al.  The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification. , 2008, Social science & medicine.

[5]  J. Bohman Public Deliberation: Pluralism, Complexity, and Democracy , 1996 .

[6]  Julia Cartwright,et al.  New Medical Technologies and Society - Reordering Life , 2005 .

[7]  S. Murray,et al.  Dying from cancer in developed and developing countries: lessons from two qualitative interview studies of patients and their carers , 2003, BMJ : British Medical Journal.

[8]  E. Heitman,et al.  Ethical Issues in Technology Assessment: Conceptual Categories and Procedural Considerations , 1998, International Journal of Technology Assessment in Health Care.

[9]  J. Eyles,et al.  Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. , 2003, Social science & medicine.

[10]  M. Berg,et al.  Technology assessment, priority setting, and appropriate care in Dutch health care , 2004, International Journal of Technology Assessment in Health Care.

[11]  M. Gold,et al.  Does providing cost-effectiveness information change coverage priorities for citizens acting as social decision makers? , 2007, Health policy.

[12]  Alexandra Plows,et al.  Listening Without Prejudice? , 2007 .

[13]  J. Pivik,et al.  A consumer involvement model for health technology assessment in Canada. , 2004, Health policy.

[14]  A. Georgiou Health technology & society: a sociological critique , 2008 .

[15]  J. Hurley,et al.  The policy analysis of 'values talk': lessons from Canadian health reform. , 2004, Health policy.

[16]  H. M. Collins,et al.  The Third Wave of Science Studies , 2002, Science, Technology, and Society.

[17]  Tiago Moreira,et al.  Diversity in clinical guidelines: the role of repertoires of evaluation. , 2005, Social science & medicine.

[18]  David Montaner,et al.  How acceptable are innovative health-care technologies? A survey of public beliefs and attitudes in England and Wales. , 2005, Social science & medicine.

[19]  Susan J. Smith,et al.  Genetics, insurance and participation: how a Citizens' Jury reached its verdict. , 2007, Social science & medicine.

[20]  S. Oliver,et al.  Consumer involvement in the health technology assessment program , 2004, International Journal of Technology Assessment in Health Care.

[21]  W. Encinosa,et al.  Technology in American Health Care: Policy Directions for Effective Evaluation and Management , 2004 .

[22]  D. Socolar,et al.  No Exit and the Organization of Voice in Biotechnology and Pharmaceuticals , 2003, Journal of health politics, policy and law.

[23]  I. Stengers,et al.  L'invention des sciences modernes , 1993 .

[24]  James D. Fearon,et al.  Deliberative Democracy: Deliberation as Discussion , 1998 .

[25]  J Gabbay,et al.  Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.

[26]  W. Otten,et al.  Implicit Normativity in Evidence-Based Medicine: A Plea for Integrated Empirical Ethics Research , 2003, Health Care Analysis.

[27]  U. Beck La société du risque : sur la voie d'une autre modernité , 2002 .

[28]  P. Lehoux The problem of health technology : policy implications for modern health care systems , 2006 .

[29]  M. Berg,et al.  Guidelines for Appropriate Care: The Importance of Empirical Normative Analysis , 2001, Health Care Analysis.

[30]  A. Webster Health, technology and society : a sociological critique , 2007 .

[31]  Susan Stocklmayer,et al.  Science Communication: A Contemporary Definition , 2003 .

[32]  Steve Fuller,et al.  The Governance of Science , 1999 .

[33]  E. Whelan 'No one agrees except for those of us who have it': endometriosis patients as an epistemological community. , 2007, Sociology of health & illness.

[34]  P. Peretti-Watel La société du risque , 2010 .